| Hassaan Jafri, MD | |
|
916 11th St, Portsmouth, OH 45662-3411 | |
| (740) 353-4884 | |
| (740) 353-8798 |
| Full Name | Hassaan Jafri |
|---|---|
| Gender | Male |
| Speciality | Hematology/oncology |
| Experience | 12 Years |
| Location | 916 11th St, Portsmouth, Ohio |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1881076263 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RH0003X | Internal Medicine - Hematology & Oncology | 35.141088 (Ohio) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| King's Daughters' Medical Center | Ashland, KY | Hospital |
| Kings Daughters Medical Center Ohio | Portsmouth, OH | Hospital |
| Southern Ohio Medical Center | Portsmouth, OH | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Kings Daughters Medical Specialties Inc | 6103968029 | 328 |
| Kings Daughters Medical Specialties Inc | 6103968029 | 328 |
News Archive
ThermoGenesis Corp. a leading supplier of innovative products and services that process and store adult stem cells, said today that it has been informed by NASDAQ that the Company is in compliance with all NASDAQ listing standards, including the minimum price bid requirement.
A team of scientists has identified MNX1 as a new oncogene - a gene than can cause cancer - that is more active in African American prostate cancer than in European American prostate cancer.
Mutations in DNA are a normal part of life. Sometimes these variations give rise to unique and beneficial traits including the creation of a new species, other times they cause devastating diseases. We are now another step closer to capturing most of the DNA mutations in humans thanks to an international study cataloging all forms of DNA variation from five populations from Europe, East Asia, South Asia, West Africa and the Americas, in the "1000 Genomes Project".
A clinical trial for types of advanced cancer is the first of its kind to show that precision medicine - or tailoring treatment for individual people - can slow down the time it takes for a tumour to grow back, according to research presented at the Molecular Analysis for Personalised Therapy (MAP) conference, today (Friday).
Researchers have developed a new algorithm that may improve upon existing methods for identifying patients at high risk for fracture in primary care.
› Verified 3 days ago
| Entity Name | Kings Daughters Medical Specialties Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1497083539 PECOS PAC ID: 6103968029 Enrollment ID: O20100114000813 |
News Archive
ThermoGenesis Corp. a leading supplier of innovative products and services that process and store adult stem cells, said today that it has been informed by NASDAQ that the Company is in compliance with all NASDAQ listing standards, including the minimum price bid requirement.
A team of scientists has identified MNX1 as a new oncogene - a gene than can cause cancer - that is more active in African American prostate cancer than in European American prostate cancer.
Mutations in DNA are a normal part of life. Sometimes these variations give rise to unique and beneficial traits including the creation of a new species, other times they cause devastating diseases. We are now another step closer to capturing most of the DNA mutations in humans thanks to an international study cataloging all forms of DNA variation from five populations from Europe, East Asia, South Asia, West Africa and the Americas, in the "1000 Genomes Project".
A clinical trial for types of advanced cancer is the first of its kind to show that precision medicine - or tailoring treatment for individual people - can slow down the time it takes for a tumour to grow back, according to research presented at the Molecular Analysis for Personalised Therapy (MAP) conference, today (Friday).
Researchers have developed a new algorithm that may improve upon existing methods for identifying patients at high risk for fracture in primary care.
› Verified 3 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Hassaan Jafri, MD Po Box 2379, Ashland, KY 41105-2379 Ph: (606) 408-6200 | Hassaan Jafri, MD 916 11th St, Portsmouth, OH 45662-3411 Ph: (740) 353-4884 |
News Archive
ThermoGenesis Corp. a leading supplier of innovative products and services that process and store adult stem cells, said today that it has been informed by NASDAQ that the Company is in compliance with all NASDAQ listing standards, including the minimum price bid requirement.
A team of scientists has identified MNX1 as a new oncogene - a gene than can cause cancer - that is more active in African American prostate cancer than in European American prostate cancer.
Mutations in DNA are a normal part of life. Sometimes these variations give rise to unique and beneficial traits including the creation of a new species, other times they cause devastating diseases. We are now another step closer to capturing most of the DNA mutations in humans thanks to an international study cataloging all forms of DNA variation from five populations from Europe, East Asia, South Asia, West Africa and the Americas, in the "1000 Genomes Project".
A clinical trial for types of advanced cancer is the first of its kind to show that precision medicine - or tailoring treatment for individual people - can slow down the time it takes for a tumour to grow back, according to research presented at the Molecular Analysis for Personalised Therapy (MAP) conference, today (Friday).
Researchers have developed a new algorithm that may improve upon existing methods for identifying patients at high risk for fracture in primary care.
› Verified 3 days ago
Hullukunte Bylappa Shivaprasad, MD Hematology & Oncology Medicare: Not Enrolled in Medicare Practice Location: 2001 Scioto Trail, Ste 200, Portsmouth, OH 45662 Phone: 740-353-8100 Fax: 740-353-8908 | |
Nadia M Chammas-aoun, M.D. Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 1735 27th St, Waller Building, Suite 108, Portsmouth, OH 45662 Phone: 740-356-6891 Fax: 740-354-6774 | |
Dr. Maja Babic, MD Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 1735 27th St, Waller Building, Suite 206, Portsmouth, OH 45662 Phone: 740-355-9240 Fax: 740-355-9281 | |
Praveena Coimbatore, Hematology & Oncology Medicare: Medicare Enrolled Practice Location: 1805 27th St, Portsmouth, OH 45662 Phone: 740-356-8867 Fax: 740-356-6784 | |
Sriharsha Velury, M.D. Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 2001 Scioto Trl Ste 200, Portsmouth, OH 45662 Phone: 740-353-8100 Fax: 740-353-8908 | |
Dr. Ronald Eugene Arrick, M.D. Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 2001 Scioto Trl Ste 200, Portsmouth, OH 45662 Phone: 740-354-8837 Fax: 740-353-7943 | |
Dr. David Kenneth Byers, M.D. Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 1735 27th St Ste 309, Portsmouth, OH 45662 Phone: 740-356-6343 Fax: 740-356-6389 |